| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 10/31/2001 | EP0775157B1 Human serum albumin-porphyrin complexes with the ability to bind oxygen and therapeutic uses thereof |
| 10/31/2001 | EP0519001B1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION |
| 10/31/2001 | EP0201540B2 Envelope antigens of lymphadenopathy associated virus and their applications |
| 10/31/2001 | CN1319400A Epiderm specificity transfer factor |
| 10/30/2001 | US6310189 Nucleotides and analogs having photoremoveable protecting groups |
| 10/30/2001 | US6310186 Purification of biological preparations |
| 10/30/2001 | US6310180 Method for synthesis of proteins |
| 10/30/2001 | US6310179 2-or 3-dimensional geometric structures |
| 10/30/2001 | US6310178 Ureins derived from α, ω-diamino acids and process for their preparation |
| 10/30/2001 | US6310105 Carboxyl-modified superabsorbent protein hydrogel |
| 10/30/2001 | US6309863 Immunizing an animal with the synthetic polypeptide which isa mimetic of the particular amino acid and is phosphorylated, collecting serum or ascitic fluid from immunized animal, screening for presence of antibodies specific for polypeptide |
| 10/30/2001 | US6309861 Process for the production of naturally folded and secreted proteins |
| 10/30/2001 | US6309859 Method for removing N-terminal methionine |
| 10/30/2001 | US6309831 Method of manufacturing biological chips |
| 10/30/2001 | US6309822 Detecting adjustments in nucleotide sequences; provide probes, mix probes with nucleic acids, detect binding of probes to preferential nucleotide sequences |
| 10/30/2001 | US6309649 The fusion (f) protein, attachment (g) protein and matrix (m) protein of respiratory syncytial virus (rsv) are isolated and purified. |
| 10/30/2001 | US6309646 Derivatizing a polysaccharide with thiols, amines, or hydrazides; reacting the derivatized polysaccharide with a vinylsulfone group; reacting the product with a protein, a peptide, or a hapten |
| 10/30/2001 | US6309602 Stacked, reconfigurable system for electrophoretic transport of charged materials |
| 10/30/2001 | US6309601 Scanning optical detection system |
| 10/30/2001 | CA2002833C Interferon-gamma binding proteins |
| 10/25/2001 | WO2001079474A1 Method for modification of proteins by transglutaminase |
| 10/25/2001 | WO2001079465A2 Nucleic acids encoding polypeptides having haloperoxidase activity |
| 10/25/2001 | WO2001079462A2 Nucleic acids encoding polypeptides having haloperoxidase activity |
| 10/25/2001 | WO2001079461A2 Polypeptides having haloperoxidase activity |
| 10/25/2001 | WO2001079459A2 Polypeptides having haloperoxidase activity |
| 10/25/2001 | WO2001079342A2 Cross-linked collagen matrices and methods for their preparation |
| 10/25/2001 | WO2001079291A2 Secreted proteins |
| 10/25/2001 | WO2001079268A2 A glycopeptide and preparation thereof |
| 10/25/2001 | WO2001079267A2 A glycopeptide and preparation thereof |
| 10/25/2001 | WO2001079260A1 Haemostatically active preparation containing vwf and method for the production thereof |
| 10/25/2001 | WO2001078878A1 Small separation apparatus |
| 10/25/2001 | WO2001078877A1 Electrophoresis separation and treatment of samples |
| 10/25/2001 | WO2000065521A3 System and method for polymer notation |
| 10/25/2001 | WO2000050160A9 Negatively charged membrane |
| 10/25/2001 | WO2000043492A9 Method of site specific labeling of proteins and uses therefor |
| 10/25/2001 | US20010034580 Methods for using functional site descriptors and predicting protein function |
| 10/25/2001 | US20010034021 Antibodies that specifically react with seroreactive regions on HPV 16 proteins E1 and E2 |
| 10/25/2001 | US20010034017 Process for the isolation and/or purification of a proteinaceous material |
| 10/25/2001 | US20010033972 Comprises nonaqueous electrolytic solution and current collector coated with active material and immersed in electrolytic solution; lightweight, useful for electric hybrid vehicles |
| 10/25/2001 | US20010032582 Filling an oil in crystallization wells, providing a cocktail and protein solutions that co-dilute, incubating, inspecting, scoring the results |
| 10/25/2001 | CA2406972A1 Cross-linked collagen matrices and methods for their preparation |
| 10/25/2001 | CA2406953A1 A glycopeptide and preparation thereof |
| 10/25/2001 | CA2405781A1 Secreted proteins |
| 10/25/2001 | CA2405038A1 Small separation apparatus |
| 10/25/2001 | CA2405033A1 Electrophoresis separation and treatment of samples |
| 10/24/2001 | EP1148063A1 Composition containing hemostatic activ vWF and process for its preparation |
| 10/24/2001 | EP1147226A2 Materials and methods for the purification of polyelectrolytes |
| 10/24/2001 | EP1147137A1 Methods for generating phosphorylation site-specific immunological reagents |
| 10/24/2001 | EP1147131A1 Alleviation of the allergenic potential of airborne and contact allergens by thioredoxin |
| 10/24/2001 | EP1147129A1 Saccharides linked to compounds that bind cell-surface peptides or proteins |
| 10/24/2001 | EP1147128A1 Binding molecules for human factor viii and factor viii-like proteins |
| 10/24/2001 | EP1147127A1 Volatilizable solid phase supports for compound synthesis |
| 10/24/2001 | EP0801686B1 Process for preparing cyclosporin a |
| 10/24/2001 | EP0731709B1 Neutrophil inhibitors from nematodes |
| 10/24/2001 | EP0618802B1 Synthetic compounds and compositions with enhanced cell binding |
| 10/24/2001 | CN1318553A New affinity chromatography medium and purification method for cobra neurotoxin |
| 10/23/2001 | US6307042 Substrate preparation process |
| 10/23/2001 | US6307032 With von willebrand factor, comprising contacting composition with an immunoaffinity chromatography material, eluting complex with first elution buffer, eluting non-complexed factor viii or von willebrand factor with second buffer |
| 10/23/2001 | US6307028 Chromatographic method for high yield purification and viral inactivation of antibodies |
| 10/23/2001 | US6307018 General chemical ligation |
| 10/23/2001 | US6307013 Separating insoluble impurities from polypeptide solution; mix anionic polymer and somatotropin solution, separate impurities and recover somatotropin |
| 10/23/2001 | US6306975 Radiation-grafted solid supports for chemical synthesis |
| 10/23/2001 | US6306637 Production of virus and purification of viral envelope proteins for vaccine use |
| 10/23/2001 | US6306628 Methods for the detection, analysis and isolation of Nascent proteins |
| 10/23/2001 | US6306580 Preparation of human papillomavirus E1 having helicase activity and method therefor |
| 10/23/2001 | US6306367 Fluorescent conjugate for differentiating between diseased and healthy tissues |
| 10/23/2001 | US6306348 Self-addressable, self-assembling microelectronic system for biological reactions e.g. nucleic acid hybridizations, antibody/antigen reactions clinical diagnostics, and biopolymer synthesis |
| 10/23/2001 | US6306306 Chromatographic process for obtaining highly purified cyclosporin A and related cyclosporins |
| 10/23/2001 | US6306272 Adding charged reactant materials to one or more channels in a chemical-reaction device; electrophoretically moving materials by supplying electrical potentials across selected electrodes in device whereby materials contact and react |
| 10/23/2001 | CA2137561C Photoactivation of proteins for conjugation purposes |
| 10/23/2001 | CA1341306C Yeast expression of urokinase-type plasminogen activator and mutants thereof |
| 10/21/2001 | CA2344887A1 Method for growing crystals |
| 10/18/2001 | WO2001077335A2 Listeria monocytogenes genome, polypeptides and uses |
| 10/18/2001 | WO2001077323A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 10/18/2001 | WO2001077208A1 Spatially defined synthesis |
| 10/18/2001 | WO2001077179A1 Proteins with a high immunoreactivity and a method for the production thereof |
| 10/18/2001 | WO2001077170A2 Multiprotein-complexes comprising a nmda receptor and uses thereof |
| 10/18/2001 | WO2001077145A2 Integrin binding peptide derivatives |
| 10/18/2001 | WO2001077141A1 Shock heat treatment of polypeptides |
| 10/18/2001 | WO2001077113A2 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties |
| 10/18/2001 | US20010032052 Apparatus and method for automated protein design |
| 10/18/2001 | US20010031858 Coupling of 2-(2-acetylamino-3-(4-amidinophenyl) propionylamino)-2-cyclohexylacetic acid with a 3-(2-amino-2-carbamoylethyl)-1-methylpyridinium salt or a salt thereof; anticoagulants |
| 10/18/2001 | US20010031476 Determining rate of bone resorption by measuring peptides in body fluid having 3-hydroxypyridinium cross-link; diagnostic tool for Paget's disease |
| 10/18/2001 | US20010031475 Cycles of pairs of components of differing molecular weights reacted with support compounds; assayed to isolate desired property and identified according to molecular weight difference; one step; libraries |
| 10/18/2001 | DE10016877A1 (Glyko-)Proteine mit hoher Immunreaktivität sowie ein Verfahren zu ihrer Herstellung (Glyco) proteins with high immunoreactivity, and a method for their preparation |
| 10/18/2001 | DE10007234A1 Peptid und dafür kodierende Nukleinsäure zur Bestimmung, Diagnostik und Therapie von Erkrankungen des Nervensystems Peptide and nucleic acid coding for determining diagnosis and treatment of diseases of the nervous system |
| 10/18/2001 | CA2405311A1 Multiprotein-complexes comprising a nmda receptor and uses thereof |
| 10/18/2001 | CA2405124A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 10/18/2001 | CA2404988A1 Listeria monocytogenes genome, polypeptides and uses |
| 10/17/2001 | EP1146121A1 Method for modification of proteins by transglutaminase |
| 10/17/2001 | EP1145012A2 Methods and kits for sequencing polypeptides |
| 10/17/2001 | EP1145010A1 Purification process using magnetic particles |
| 10/17/2001 | EP1144619A1 Method of ultrafiltration |
| 10/17/2001 | EP1144587A1 Device for carrying out the cell-free synthesis of proteins |
| 10/17/2001 | EP1144434A2 Combinatorial process for preparing polyamines |
| 10/17/2001 | EP1144433A2 Method for combinatorial materials development |
| 10/17/2001 | EP1143929A1 BIODEGRADABLE pH/THERMOSENSITIVE HYDROGELS FOR SUSTAINED DELIVERY OF BIOLOGICALLY ACTIVE AGENTS |
| 10/17/2001 | EP1113817A4 Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies |
| 10/17/2001 | EP0617706B1 Multivalent antigen-binding proteins |
| 10/17/2001 | CN1318069A Factor VIIa inhibitors |